Abstract:The synovial membrane is composed of fibroblast-like cells (synovial fibroblasts) and macrophage-like cells. Synovial fibroblasts and monocytes/macrophages are believed to interact and to play a critical role in the development of synovial inflammation. In this study, we investigated the protein production of pro-inflammatory cytokines in co-culture of synovial fibroblasts isolated from the temporomandibular joint (TMJ) and monocytes isolated from peripheral blood. Monocytes that had attached to the plastic su… Show more
“…Moreover, higher degrees of IL-1α and IL-1β in the synovial fluid of patients with TMD were indicated in various works of research [27]. Meanwhile, few studies examined fibroblasts, which were cultured from TMJ synovial fluid [32,35] and TMJ synovial biopsies (immunohistochemistry) [46,52], leading to consistent results. Furthermore, a study by Ok et al 2018 [34] demonstrated that the level of urinary pyridinoline (PYD) and deoxypyridinoline (DPD) were increased in patients with TMDs.…”
Section: Tmds Inflammatory Biomarkersmentioning
confidence: 95%
“…Moreover, several synovial, serum and urinary proteins were found to exhibit important diagnostic tool for TMDs (Table 1). [33] Wilkes classification Synovial fluid IL-8, sTNFR1, sTNFR2 and sIL-6R Ok et al, 2018 [34] RDC-TMD Urine PYD and DPD Watanabe et al, 2017 [35] Arthroscopy of the TMJ TMJ synovial fibroblasts IL-1β, IL-6, and IL-8…”
Numerous studies have been conducted in the previous years with an objective to determine the ideal biomarker or set of biomarkers in temporomandibular disorders (TMDs). It was recorded that tumour necrosis factor (TNF), interleukin 8 (IL-8), IL-6, and IL-1 were the most common biomarkers of TMDs. As of recently, although the research on TMDs biomarkers still aims to find more diagnostic agents, no recent study employs the biomarker as a targeting point of pharmacotherapy to suppress the inflammatory responses. This article represents an explicit review on the biomarkers of TMDs that have been discovered so far and provides possible future directions towards further research on these biomarkers. The potential implementation of the interactions of TNF with its receptor 2 (TNFR2) in the inflammatory process has been interpreted, and thus, this review presents a new hypothesis towards suppression of the inflammatory response using TNFR2-agonist. Subsequently, this hypothesis could be explored as a potential pain elimination approach in patients with TMDs.
“…Moreover, higher degrees of IL-1α and IL-1β in the synovial fluid of patients with TMD were indicated in various works of research [27]. Meanwhile, few studies examined fibroblasts, which were cultured from TMJ synovial fluid [32,35] and TMJ synovial biopsies (immunohistochemistry) [46,52], leading to consistent results. Furthermore, a study by Ok et al 2018 [34] demonstrated that the level of urinary pyridinoline (PYD) and deoxypyridinoline (DPD) were increased in patients with TMDs.…”
Section: Tmds Inflammatory Biomarkersmentioning
confidence: 95%
“…Moreover, several synovial, serum and urinary proteins were found to exhibit important diagnostic tool for TMDs (Table 1). [33] Wilkes classification Synovial fluid IL-8, sTNFR1, sTNFR2 and sIL-6R Ok et al, 2018 [34] RDC-TMD Urine PYD and DPD Watanabe et al, 2017 [35] Arthroscopy of the TMJ TMJ synovial fibroblasts IL-1β, IL-6, and IL-8…”
Numerous studies have been conducted in the previous years with an objective to determine the ideal biomarker or set of biomarkers in temporomandibular disorders (TMDs). It was recorded that tumour necrosis factor (TNF), interleukin 8 (IL-8), IL-6, and IL-1 were the most common biomarkers of TMDs. As of recently, although the research on TMDs biomarkers still aims to find more diagnostic agents, no recent study employs the biomarker as a targeting point of pharmacotherapy to suppress the inflammatory responses. This article represents an explicit review on the biomarkers of TMDs that have been discovered so far and provides possible future directions towards further research on these biomarkers. The potential implementation of the interactions of TNF with its receptor 2 (TNFR2) in the inflammatory process has been interpreted, and thus, this review presents a new hypothesis towards suppression of the inflammatory response using TNFR2-agonist. Subsequently, this hypothesis could be explored as a potential pain elimination approach in patients with TMDs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.